IMM Immupharma Plc

TIDMIMM

RNS Number : 4022Q

Immupharma PLC

06 June 2018

 
   6 June 2018 
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS

NOTICE OF ANNUAL GENERAL MEETING ON 28 JUNE 2018 @ 10.30 AM

VENUE: SKY LIGHT CITY TOWER, 50 BASINGHALL STREET, LONDON, EC2

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2017 has been posted to shareholders.

This report includes the 'Annual Report of the Annual General Meeting' ('AGM') as well as the 'Notice of the 2018 AGM', which will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

ImmuPharma's AGM will be held on Thursday 28 June at 10:30am at Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.

-Ends-

 
 
 For further information please contact: 
                                                       + 44 (0) 20 
   ImmuPharma plc (www.immupharma.co.uk)                7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor Relations           + 44 (0) 7721 
    Twitter: @immupharma                                413496 
 
   Northland Capital Partners Limited (NOMAD & 
    Joint Broker) 
    David Hignell, Dugald Carlean, Jamie Spotswood, 
    Corporate Finance                                  +44 (0)20 3861 
    Rob Rees, Corporate Broking                         6625 
   Bryan, Garnier & Co. (Joint Broker) +44 (0)20 7332 2500 
    Phil Walker, Corporate Finance 
    Dominic Wilson, Sales 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NOALLFSERAIEIIT

(END) Dow Jones Newswires

June 06, 2018 02:01 ET (06:01 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024